SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert Knight who wrote (683)7/1/1998 12:20:00 AM
From: jake burns  Read Replies (1) of 1510
 
Robert, after viewing the trading the past 3 days, is it your belief that cibc oppenheimer has yet to begin to buy back ANY of the shares they are short? In other words, are they still not convinced that IMNR is for real? Seems to me a more prudent strategy, given the downside risk, would be to buy back as many shares as possible in the 15 dollar range while they still have the chance...but they haven't done so, right?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext